SynthesisBMC geriatrics2025
Prevalence and course of depression in older people with aortic stenosis undergoing transcatheter aortic valve implantation - a systematic review and meta-analysis.
Synthesis in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- External factors show reproducible local symptom-biomarker associations in middle-aged and older adults with heart disease.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDepression is the most prevalent psychiatric disorder in older people with cardiovascular disease and an independent risk factor for cardiac surgery outcomes. Given the rising number of older people with aortic stenosis in need of transcatheter aortic valve implantation (TAVI) and the increasingly recognized role of depression as a prognostic factor, this systematic review and meta-analysis aimed to derive a global estimate of the prevalence of depression and to examine its course from pre- to post-TAVI.
methodsWe included articles reporting prevalence of depression (diagnosed or assessed using validated instruments) or change in depressive symptoms in people undergoing TAVI. We performed three main meta-analyses: (1) prevalence of diagnosed depression, (2) prevalence of assessed depression and (3) standardized mean change (SMC) of depressive symptoms from pre- to post-TAVI.
resultsWe included 32 studies in this systematic review, 26 of which were suitable for meta-analysis. The pooled prevalence of diagnosed and assessed depression was 6.0% [95%-Confidence interval: 3.3, 10.6] and 18.5% [13.0, 25.6], respectively. We observed a small, albeit non-significant trend towards a decrease in depressive symptoms from pre- to post-TAVI (SMC: -0.08 [-0.37, 0.22]).
conclusionsA relevant proportion of people undergoing TAVI experiences depression, and the discrepancy in prevalence estimates of diagnosed and assessed depression indicates a potential under-diagnosis of depression. Disease management strategies should be adapted to include screening for and adequate treatment of depression in this population. Improvement of depressive symptoms after TAVI should not be taken for granted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.